236 related articles for article (PubMed ID: 18372406)
1. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S
J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.
Chen D; Washbrook E; Sarwar N; Bates GJ; Pace PE; Thirunuvakkarasu V; Taylor J; Epstein RJ; Fuller-Pace FV; Egly JM; Coombes RC; Ali S
Oncogene; 2002 Jul; 21(32):4921-31. PubMed ID: 12118371
[TBL] [Abstract][Full Text] [Related]
3. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
Cheng J; Zhang C; Shapiro DJ
Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152
[TBL] [Abstract][Full Text] [Related]
4. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
[TBL] [Abstract][Full Text] [Related]
5. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
6. Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen.
Glaros S; Atanaskova N; Zhao C; Skafar DF; Reddy KB
Mol Endocrinol; 2006 May; 20(5):996-1008. PubMed ID: 16455819
[TBL] [Abstract][Full Text] [Related]
7. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
[TBL] [Abstract][Full Text] [Related]
8. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induced phosphorylation of estrogen receptor at serine 118 in the absence of ligand.
Park J; Lee Y
J Steroid Biochem Mol Biol; 2017 Nov; 174():146-152. PubMed ID: 28847747
[TBL] [Abstract][Full Text] [Related]
10. Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.
Bratton MR; Antoon JW; Duong BN; Frigo DE; Tilghman S; Collins-Burow BM; Elliott S; Tang Y; Melnik LI; Lai L; Alam J; Beckman BS; Hill SM; Rowan BG; McLachlan JA; Burow ME
J Endocrinol; 2012 Jul; 214(1):45-54. PubMed ID: 22562654
[TBL] [Abstract][Full Text] [Related]
11. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
12. Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2.
Williams CC; Basu A; El-Gharbawy A; Carrier LM; Smith CL; Rowan BG
BMC Biochem; 2009 Dec; 10():36. PubMed ID: 20043841
[TBL] [Abstract][Full Text] [Related]
13. Bisphenol AF-induced endogenous transcription is mediated by ERα and ERK1/2 activation in human breast cancer cells.
Li M; Guo J; Gao W; Yu J; Han X; Zhang J; Shao B
PLoS One; 2014; 9(4):e94725. PubMed ID: 24727858
[TBL] [Abstract][Full Text] [Related]
14. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of p42/44(MAPK) by various signal transduction pathways activates cytosolic phospholipase A(2) to variable degrees.
van Rossum GS; Klooster R; van den Bosch H; Verkleij AJ; Boonstra J
J Biol Chem; 2001 Aug; 276(31):28976-83. PubMed ID: 11390384
[TBL] [Abstract][Full Text] [Related]
16. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
Rabenoelina F; Semlali A; Duchesne MJ; Freiss G; Pons M; Badia E
Int J Cancer; 2002 Apr; 98(5):698-706. PubMed ID: 11920638
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry.
Bayraktar UD; Kim TK; Drews-Elger K; Benjamin C; El-Ashry D; Wieder E; Komanduri KV
Breast Cancer Res Treat; 2011 Sep; 129(2):623-8. PubMed ID: 21607585
[TBL] [Abstract][Full Text] [Related]
18. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
Cale JM; Bird IM
Biochem J; 2006 Sep; 398(2):279-88. PubMed ID: 16716148
[TBL] [Abstract][Full Text] [Related]
20. Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.
Bayliss J; Hilger A; Vishnu P; Diehl K; El-Ashry D
Clin Cancer Res; 2007 Dec; 13(23):7029-36. PubMed ID: 18056179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
